Page 41 - Syndipharma
P. 41

CinnaGen Co.

            IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY




                Founded:                     1994 by a group of scientists
                HQ Office:                   No. 2, 7  St., Simaye Iran St., Shahrak Gharb, Tehran, Iran, Zip-code: 1467635165
                                                   th
                Plant Location:              Simin Dasht Industrial Area, Karaj, Iran.

                Capital:                     1,000,000,000,000 Iranian Rials

                Major Shareholder:           Individuals from private sector

                Employees:                   675
                 Company Profile:
                 Since its start of operation with 4 scientists, CinnaGen has grown to become the biggest biopharmaceutical manufacturer
                 and exporter in the region. CinnaGen focuses its efforts on developing biosimilar candidates in the areas of
                 immunological diseases, infertility, hormone disorders and oncology as well as providing contract research development
                 services.  The  company  is  spending  over  20  percent  of  its  annual  total  turnover  on  R&D  activities.  CinnaGen  is
                 strategically positioned to become and remain a leading biotechnology company in the region. CinnaGen aim is to
                 develop hi-tech medicines to promote sustainable development in human health.
                 Production Lines:
                 CinnaGen production facilities consist of 20,000 m2 total working area and 5,800 m2 clean rooms for biopharmaceutical
                 manufacturing in full compliance with EU GMP regulations. By relying on its professional human resource and scientific
                 background, CinnaGen has been able to perform its entire production procedure from design to dispatch in its facilities.
                 Premier Partners :
                 CinnaGen is an active international company by having joint venture projects in Turkey, Russia and Latin America
                 for local manufacturing, technology transfer and facility construction. In 2013 CinnaGen started the registration of
                 CinnoVex®, its flagship product in the European Union. As a 4-year winner of the Top Exporter Prize, CinnaGen has
                 established different partnerships around the world for registration, marketing and sales of its products.
                 Certificates:
                      • ISO 9001:2015
                      • ISO 14001: 2015
                      • OHSAS 18001:2007
                      • ISO 10015:1999
                      • ISO 10002:2014
                      • GMP - Iranian Ministry of Health
                      • GMP - Turkey Ministry of Health
                      • GMP – Kazakhstan Ministry of Health
                      • GMP – Russian Ministry of Health
                      • GMP – Colombian Ministry of Health

                Therapeutic Groups and Pharmaceuticals with Capacity for Exports :
                Treatment

                Target Countries for Exports:
                MENA: Middle East and North Africa, LATAM: Latin America, EU: Europe, CIS: Commonwealth of Independent States.

                Contact details:
                Head Office : No.2, 7  St., Simaye Iran St., Shahrak Gharb, Tehran, Iran, Zip-code: 1467635165
                                 th
                Factory: Simin Dasht Industrial Area, Karaj, Iran.
                Tel. Office: +98-021-42 815
                Fax: +98-021-88 56 15 57
                Website: www.cinnagen.com
                Tel. Plant: +98-0263 66 70 334-341
                E-mail: cinnagen@cinnagen.com
          40    Fax: +98-0263 66 70 337
   36   37   38   39   40   41   42   43   44   45   46